Web Access Research Portal

Researcher: Taylor, BVM (Professor Bruce Taylor)

Fields of Research

Central Nervous System
Epidemiology
Neurology and Neuromuscular Diseases
Peripheral Nervous System
Medical Genetics (excl. Cancer Genetics)
Health Economics
Health, Clinical and Counselling Psychology
Neurogenetics
Mental Health
Rehabilitation and Therapy (excl. Physiotherapy)
Genetics
Preventive Medicine
Clinical Sciences
Immunology
Autoimmunity
Cellular Nervous System
Health Information Systems (incl. Surveillance)
Neurosciences
Cellular Immunology
Genomics
Infectious Diseases
Proteins and Peptides
Autonomic Nervous System
Immunogenetics (incl. Genetic Immunology)
Medical and Health Sciences
Quantitative Genetics (incl. Disease and Trait Mapping Genetics)
Sensory Systems
Epigenetics (incl. Genome Methylation and Epigenomics)
Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology)
Endocrinology
Anaesthesiology
Medicine, Nursing and Health Curriculum and Pedagogy
Nutrition and Dietetics
Health Promotion
Medical Microbiology
Psychiatry (incl. Psychotherapy)
Immunological and Bioassay Methods
Probability Theory
Innate Immunity
Public Health and Health Services
Basic Pharmacology
Complementary and Alternative Medicine
Clinical Pharmacology and Therapeutics
Systems Physiology
Educational Technology and Computing
Biologically Active Molecules
Tumour Immunology
Cell and Nuclear Division
Population, Ecological and Evolutionary Genetics
Cell Physiology
Pharmacology and Pharmaceutical Sciences
Regenerative Medicine (incl. Stem Cells and Tissue Engineering)
Medical Physiology
Ophthalmology

Research Objectives

Nervous System and Disorders
Preventive Medicine
Inherited Diseases (incl. Gene Therapy)
Immune System and Allergy
Infectious Diseases
Mental Health
Disease Distribution and Transmission (incl. Surveillance and Response)
Clinical Health (Organs, Diseases and Abnormal Conditions)
Health
Behaviour and Health
Specific Population Health (excl. Indigenous Health)
Expanding Knowledge in the Biological Sciences
Public Health (excl. Specific Population Health)
Expanding Knowledge in the Medical and Health Sciences
Health Education and Promotion
Environmental Health
Diabetes
Cancer and Related Disorders
Neurodegenerative Disorders Related to Ageing
Allied Health Therapies (excl. Mental Health Services)
Human Biological Preventatives (e.g. Vaccines)
Human Diagnostics
Blood Disorders
Skeletal System and Disorders (incl. Arthritis)
Expanding Knowledge in Economics
Human Pharmaceutical Treatments (e.g. Antibiotics)
Evaluation of Health Outcomes
Expanding Knowledge in Psychology and Cognitive Sciences
Health Policy Evaluation
Health and Support Services
Disability and Functional Capacity
Skin and Related Disorders
Health Status (e.g. Indicators of Well-Being)
Injury Control
Human Pharmaceutical Products
Social Structure and Health

Career Best Publications

Research Publications

Varicella zoster virus quantitation in blood from symptomatic and asymptomatic individuals; Journal of Medical Virology
A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis; PLoS One
A new era in the treatment of multiple sclerosis; Medical Journal of Australia
A New Method for Targeted and Sustained Induction of Type 2 Diabetes in Rodents; Scientific Reports
A novel approach for prediction of vitamin D status using support vector regression; PLoS One
A novel method for calculating prevalence of multiple sclerosis in Australia; Multiple Sclerosis
A polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosis; PLoS ONE
A potentiation of the adverse effect of human leukocyte antigen-DR15 on the risk of multiple sclerosis by low infant sibling exposure: a population based case-control study; 13th Annnual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis
A profile of the Multiple Sclerosis Longitudinal Study: Evaluating environmental, behavioural and genetic predictors of clinical outcomes in multiple sclerosis; Australasian Epidemiologist
A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis; Human Molecular Genetics
A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis; Nature Communications
A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in Multiple Sclerosis ; P L o S One
Acute inflammatory encephalomyelitis following Campylobacter enteritis associated with high titre antiganglioside GM1 IgG antibodies; Journal of Clinical Neuroscience
Adherence to MRI protocol consensus guidelines in multiple sclerosis: An Australian multi-centre study; Journal of Medical Imaging and Radiation Oncology
Adherence to the immunomodulatory drugs for multiple sclerosis: contrasting factors affect stopping drug and missing doses; Pharmacoepidemiology and Drug Safety
Adverse lipid profile is not associated with relapse risk in MS: Results from an observational cohort study; Journal of the Neurological Sciences
Altered Corticomotor Representation in Patients with Parkinson's Disease; Movement Disorders
An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating event; Journal of Neurology, Neurosurgery and Psychiatry
An adverse lipid profile is associated with disability and progression in disability, in people with MS; Multiple Sclerosis Journal
Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class 1 region in Tasmanian MS patients; Immunogenetics
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis; Nature Genetics
Analytical bias in the measurement of serum 25-hydroxyvitamin D concentrations impairs assessment of vitamin D Status in clinical and research settings; PL o S One
Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis; Multiple sclerosis journal
Anxiety, depression and fatigue at 5-year review following CNS demyelination; Acta Neurologica Scandinavica
Apolipoprotein E4 genotype does not influence multiple sclerosis phenotype, severity, cognition or brain atrophy in a large Australian cohort; 13th Annnual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis
Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy; Neurology
Assessing interactions between HLA-DRB1*15 and infectious mononucleosis on the risk of multiple sclerosis; Multiple Sclerosis
Assessing possible selection bias in a national voluntary MS longitudinal study in Australia; Multiple Sclerosis
Association between exposure to farm animals and pets and risk of Multiple Sclerosis; Multiple Sclerosis and Related Disorders
Association between human herpesvirus & human endogenous retrovirus and MS onset & progression; Journal of the Neurological Sciences
Association between multiple sclerosis risk-associated SNPs and relapse and disability - a prospective cohort study; Multiple Sclerosis
Associations between Silicone Skin Cast Score, Cumulative Sun Exposure, and Other Factors in the Ausimmune Study: A Multicenter Australian Study ; Cancer Epidemiology, Biomarkers and Prevention
Asthma onset prior to multiple sclerosis and the contribution of sibling exposure in early life; Clinical and Experimental Immunology
Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity; Neurology
Axonopathy in peripheral neuropathies: Mechanisms and therapeutic approaches for regeneration; Journal of Chemical Neuroanatomy
Birth order, infection in early life, and multiple sclerosis; The Lancet Neurology
Challenges in exposure and outcome definition in neuroepidemiology: the case of vitamin D and multiple sclerosis; Australasian Epidemiologist
Change in multiple sclerosis prevalence over time in Australia 2010-2017 utilising disease modifying therapy prescription data; Multiple Sclerosis Journal
Chronic inflammatory demyelinating polyneuropathy complicating liver transplantation; Annals of Neurology
Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype; Journal of Neurology, Neurosurgery and Psychiatry
Class II HLA interactions modulate genetic risk for multiple sclerosis; Nature Genetics
Clinical characteristics and longitudinal course of multifocal motor neuropathy with persistent conduction block (MMN-PCB); Peripheral Nerve Society
Clinically isolated acute transverse myelitis: prognostic features and incidence; Multiple Sclerosis
Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects; Journal of Medical Genetics
Closing the gap: Longitudinal changes in employment for Australians with multiple sclerosis; Multiple Sclerosis Journal
Cold sweat case report; The Lancet
Common genetic variation within miR-146a predicts disease onset and relapse in multiple sclerosis; Neurological Sciences
Comparing genotyping algorithms for Illumina's Infinium whole-genome SNP BeadChips; BMC Bioinformatics
Comparison of cognitive function in euthymic bipolar disorder and focal epilepsy arising from the temporal lobes: Systematic review
Comparison of precipitating factors for mania and partial seizures: Indicative of shared pathophysiology?; Journal of Affective Disorders
Complementary and alternative treatments of multiple sclerosis: a review of the evidence from 2001 to 2016; Journal of Neurology, Neurosurgery and Psychiatry
Composite ganglioside autoantibodies and immune treatment response in MMN and MADSAM; Muscle and Nerve
Concurrence of precipitating factors in mania and partial seizures arising from the temporal lobes; Australasian Society for Bipolar and Depressive Disorders Conference
Contribution of different relapse phenotypes to disability in multiple sclerosis; Multiple Sclerosis Journal
CTLA-4 and multiple sclerosis: The A49G single nucleotide polymorphism shows no association with multiple sclerosis in a Southern Australian population; Journal of Neuroimmunology
CU3 – Life Expectancy, Quality-Adjusted Life Years, and Total Lifetime Costs for Australian People with Multiple Sclerosis; Value in Health
Current and past Epstein-Barr virus infection in risk of initial CNS demyelination; Neurology
Diabetic amyotrophy progressing to severe quadriparesis; Muscle & Nerve
Diabetic nerve vulnerability to ischaemia; Journal Watch Neurology
Diabetic neuropathies. Classification, clinical features, and pathophysiological basis; The Neurologist
Disability profile of multiple sclerosis in New Zealand; Journal of Clinical Neuroscience
Early-life hygiene-related factors affect risk of central nervous system demyelination and asthma differentially; Clinical and Experimental Immunology
EBV & HHV6 reactivation is infrequent and not associated with MS clinical course; Acta Neurologica Scandinavica
Effects of multiple sclerosis disease-modifying therapies on employment measures using patient-reported data; Journal of Neurology, Neurosurgery and Psychiatry
Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma; Journal of Clinical Oncology
Electrophysiological characterization of multifocal motor neuropathy (MMN) with persistent motor conduction block (PCB); Peripheral Nerve Society
Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms
Epstein Barr viral infection and onset of central nervous system demyelination; 15th Annual Meeting of the Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis
Epstein-Barr virus and multiple sclerosis; Journal of Neurology, Neurosurgery and Psychiatry
Epstein-Barr virus infection: a smoking gun for multiple sclerosis?; Neurology
Estimating MS-related work productivity loss and factors associated with work productivity loss in a representative Australian sample of people with multiple sclerosis; Multiple Sclerosis Journal
Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis; Human Molecular Genetics
Estimation of annual probabilities of changing disability levels in Australians with relapsing-remitting multiple sclerosis; Multiple Sclerosis Journal
Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility; Genome Medicine
Exposure to infant siblings during early life and risk of multiple sclerosis; Journal of the American Medical Association
Exposure to infant siblings during early life and risk of multiple sclerosis: reply to Ruprecht and Peron; Journal of the American Medical Association
Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis; Human Genetics
Extracranial metastases of a glioblastoma multiforme to the pleura, small bowel and pancreas; Journal of Clinical Neuroscience
Familial recurrence risks for multiple sclerosis in Australia; Journal of Neurology, Neurosurgery and Psychiatry
Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus; Journal of Neuroimmunology
Fine-mapping the genetic association of the major histocompatibility complex in Multiple Sclerosis: HLA and non-HLA effects; PLoS Genetics
Frequency of comorbidities and their association with clinical disability and relapse in Multiple Sclerosis; Neuroepidemiology
Genes implicated in multiple sclerosis pathogenesis fromconsilience of genotyping and expression profiles in relapse and remission; BMC Medical Genetics
Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis; American Journal of Human Genetics
Genetic loci for Epstein-Barr virus nuclear antigen-1 are associated with risk of multiple sclerosis; Multiple Sclerosis Journal
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis; Nature
Genetic variants are major determinants of CSF antibody levels in multiple sclerosis; Brain
Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis; Annals of Neurology
Genetic variation in PBMC-produced IFN-γ and TNF-α associations with relapse in multiple sclerosis; Journal of The Neurological Sciences
Genetic variation in the gene LRP2 increases relapse risk in multiple sclerosis; Journal of Neurology, Neurosurgery and Psychiatry
Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis; Annals of Neurology
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20; Nature Genetics
Genome-Wide Meta-Analysis Identifies Novel Multiple Sclerosis Susceptibility Loci; Annals of Neurology
Genomic effects of the vitamin D receptor: Potentially the link between vitamin D, immune cells, and multiple sclerosis; Frontiers in Immunology
Genotype and phenotype in Multiple Sclerosis - potential for disease course prediction?; Current Treatment Options in Neurology
Geographical variations in sex ratio trends over time in multiple sclerosis; PLoS ONE
Grand rounds a 24 year old man with upper limb weakness, pain and sensory loss. Case report and comments; Journal of The Neuromusculoskeletal System
Guillain-Barré syndrome complicating treatment with streptokinase; Medical Journal of Australia
Health Economic Impact of Multiple Sclerosis in Australia in 2017: An analysis of MS Research Australia’s platform – the Australian MS Longitudinal Study (AMSLS)
Hereditary diffuse leucoencephalopathy with spheroids; Journal of Neurology, Neurosurgery and Psychiatry
Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognition ; Multiple Sclerosis
Higher 25-hydroxyvitamin D is associated with lower relapse risk in Multiple Sclerosis; Annals of Neurology
Higher intake of omega-3 polyunsaturated fatty acids is associated with a decreased risk of a first clinical diagnosis of central nervous system demyelination: Results from the Ausimmune Study; Multiple Sclerosis
Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis; Journal of Neurology, Neurosurgery and Psychiatry
Higher levels of reported sun exposure, and not vitamin D status, are associated with less depressive symptoms and fatigue in multiple sclerosis; Acta Neurologica Scandinavica
HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis; Tissue Antigens
Human Leukocyte Antigen-DR15, Low Infant Sibling Exposure and Multiple Sclerosis: Gene-Environment Interaction; Annals of Neurology
Identification of novel neurotrophic-like factors: a candidate for promoting nerve regeneration in neuropathy; ANS Adelaide 2014
Identity-by-Descent Mapping to Detect Rare Variants Conferring Susceptibility to Multiple Sclerosis; PLoS ONE
Imaging and diagnostic criteria for Multiple Sclerosis: Are we there yet?; Journal of Medical Imaging and Radiation Oncology
Incidence and prevalence of NMOSD in Australia and New Zealand; Journal of Neurology, Neurosurgery and Psychiatry
Increasing incidence of ALS in Canterbury, New Zealand: A 22-year study; Neurology
Individual and Joint Action of Environmental Factors and Risk of MS
Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS; Neurology
Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis; International Journal of Molecular Sciences
Investigation of the role of pregnancy and exposure to biological children in the onset of central nervous system demyelination; 15th Annual Meeting of the Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis
Ireland: a fine place for multiple sclerosis research; Journal of Neurology, Neurosurgery and Psychiatry
Is your association real or just reverse causality? Some examples from analyses of multiple sclerosis clinical course and tools to assess it; Australasian Epidemiologist
Isolated unilateral hypoglossal nerve paralysis caused by an atlanto-occipital joint synovial cyst; Journal of Clinical Neuroscience
Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression; Scientific Reports
Latitude continues to be significantly associated with the prevalence of multiple sclerosis: an updated meta-analysis; Journal of Neurology, Neurosurgery and Psychiatry
Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis; Journal of Neurology, Neurosurgery and Psychiatry
Latitudinal variation in incidence and type of first central nervous system demyelinating events; Multiple Sclerosis
Latitudinal variation in incidence of first demyclinating events: descriptive analyses of case participants in the Ausimmune Study; 13th Annnual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis
Lipid-related genetic polymorphisms significantly modulate the association between lipids and disability progression in multiple sclerosis; Journal of Neurology, Neurosurgery and Psychiatry
Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis; Multiple Sclerosis Journal
Low-density lipoprotein receptor-related proteins guide navigating PNS axons; 2015 PNS Meeting
Low-density lipoprotein receptor-related proteins in a novel mechanism of axon guidance and peripheral nerve regeneration; Journal of Biological Chemistry
Low-frequency and rare-coding variation contributes to multiple sclerosis risk; Cell
Low-frequency synonymous coding variation in CYP2R1 has large effects on Vitamin D levels and risk of multiple sclerosis; American Journal of Human Genetics
LRP receptors in a novel mechanism of axon pathfinding and peripheral nerve regeneration; Neuroscience 2014
Magnetic resonance imaging in cancer-related lumbosacral plexopathy; Mayo Clinic Proceedings
Mania associated with herbal medicines, other than Cannabis: a systematic review and quality assessment of case reports; Frontiers in Psychiatry
Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dye ; Virology Journal
Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis; Neurology
Meta-analyses to investigate gene-environment interactions in neuroepidemiology; Neuroepidemiology
Metallothionein I/II and metallothionein III induce growth cone chemotaxis via disparate mechanisms; Australian Neuroscience Society 31st Annual Meeting
Metallothionein I/II induces growth cone chemotaxis via an LRP­1 and LRP­2 dependent mechanism; Neuroscience 2012
Metallothionein I/II induces growth cone chemotaxis via an LRP­1 and LRP­2 dependent mechanism; Neuroscience 2012
Method for identifying eligible individuals for a prevalence survey in the absence of a disease register or population register; Internal Medicine Journal
MicroRNAs miR-17 and miR-20a Inhibit T Cell Activation Genes and Are Under-Expressed in MS Whole Blood; P L o S One
Midsagittal corpus callosum area and conversion to multiple sclerosis after clinically isolated syndrome: A multicentre Australian cohort study; Journal of Medical Imaging and Radiation Oncology
Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data; Genome Medicine
Modelling the impact of multiple sclerosis on life expectancy, quality-adjusted life years and total lifetime costs: Evidence from Australia; Multiple Sclerosis Journal
Modulating effects of WT1 on interferon-β-vitamin D association in MS; Acta Neurologica Scandinavica
Monthly ambient sunlight, infections and relapse rates in multiple sclerosis; Neuroepidemiology
Monthly ambient sunlight, vitamin D, infections and relapse rates in multiple sclerosis; 13th Annnual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis
MS prevalence in New Zealand, an ethnically and latitudinally diverse country ; Multiple Sclerosis
Multifocal motor neuropathy: pathologic alterations at the site of conduction block; Journal of Neuropathology and Experimental Neurology
Multiple Quantitative Trait Loci for Anti-EBNA-1 IgG Titres are Associated with Risk of Multiple Sclerosis
Multiple Sclerosis impact on employment and income in New Zealand; Acta Neurologica Scandinavica
Multiple sclerosis in New Zealand Māori; Multiple Sclerosis Journal
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies; Neurology: Genetics
Multiple Sclerosis Susceptibility-Associated SNPs Do Not Influence Disease Severity Measures in a Cohort of Australian MS Patients; P L o S One
Multiple Sclerosis: a haplotype association study; Novartis Foundations Symposium
Natural history of 46 patients with multifocal motor neuropathy with conduction block; Muscle and Nerve
Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls; American Journal of Human Genetics: A Record of Research, Review and Bibliographic Material Relating to Heredity in Man
Neuroglial responses to CNS injury: prospects for novel therapeutics; Expert Review of Neurotherapeutics
No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis; Human Molecular Genetics
Non-Obese Diabetes and Its Associated Factors in an Underdeveloped Area of South China, Guangxi; International Journal of Environmental Research and Public Health
Novel modulating effects of PKC family genes on the relationship between serum vitamin D and relapse in multiple sclerosis; Journal of Neurology, Neurosurgery and Psychiatry
Observational analytic studies in multiple sclerosis: controlling bias through study design and conduct. The Australian Multicentre Study of Environment and Immune Function; Multiple Sclerosis
Occupational Exposure and Risk of Central Nervous System Demyelination; American Journal of Epidemiology
Office immunotherapy in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy; Muscle and Nerve
Offspring number, pregnancy, and risk of a first clinical demyelinating event: The AusImmune Study; Neurology
Onset symptoms, tobacco smoking, and progressive-onset phenotype are associated with a delayed onset of multiple sclerosis, and marijuana use with an earlier onset; Frontiers in Neurology
OPL110 Clinical-MRI correlates in multiple sclerosis: Correlation of EDSS, MSFC, fatigue and depression measures with FLAIR, T1 volume and diffusion measures of normal-appearing white matter; Journal of the Neurological Sciences
Overlap of precipitating factors in mania and partial seizures: in pursuit of shared pathophysiology; 17th Annual Conference of the International Society for Bipolar Disorders
Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction ; Multiple Sclerosis
Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study; British Medical Journal
Past sun exposure, skin phenotype and risk of multiple sclerosis: a case-control study; 15th Conference of the International Society for Environmental Epidemiology 2003
Patient-reported outcomes are worse for progressive-onset multiple sclerosis than relapse-onset multiple sclerosis, particularly early in the disease process; European Journal of Neurology
PND13 – Assessing Health-State Utility Values in Australian People with Multiple Sclerosis; Value in Health
Polymorphism in the serotonin transporter gene polymorphisms (5-HTTLPR) modifies the association between significant life events and depression in people with multiple sclerosis; Multiple Sclerosis Journal
Polymorphisms in the Receptor Tyrosine Kinase MERTK Gene Are Associated with Multiple Sclerosis Susceptibility; PL o S One
Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis; Multiple Sclerosis and Related Disorders
Population attributable fractions and joint effects of key risk factors for multiple sclerosis; Multiple Sclerosis Journal
Predicting MS progression: patience is a virtue; Journal of Neurology, Neurosurgery and Psychiatry
Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis; Multiple Sclerosis
Progressive dural venous sinus thrombosis treated with local streptokinase infusion; Journal of Neurology, Neurosurgery and Psychiatry
Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians; Genes and Immunity
Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes; Human Molecular Genetics
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study; Pharmacogenomics Journal
Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study; Journal of Neurology, Neurosurgery and Psychiatry
Role of vitamin D in multiple sclerosis: implications for disease management
Saliva-Derived DNA Performs Well in Large-Scale, High-Density Single-Nucleotide Polymorphism Microarray Studies; Cancer Epidemiology, Biomarkers and Prevention
Searching for rare variants conferring susceptibility to multiple sclerosis; Progress in MS Research Conference
Sensitivity and specificity of serology in determining recent acute Campylobacter infection; Internal Medicine Journal
Serological evidence for infection with Campylobacter jejuni/coli in patients with multifocal motor neuropathy; Journal of Clinical Neuroscience
Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients; Journal of Neurology, Neurosurgery and Psychiatry
Severe persistent sciatic pain and weakness due to a gluteal artery pseudoaneurysm as a complication of bone marrow biopsy; Journal of Clinical Neuroscience
Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis ; Journal of Neurology: Official Journal of The European Neurological Society
SNP mapping and candidate gene sequencing in the class 1 region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians; Tissue Antigens
Stimulated PBMC-produced IFN-γ and TNF-α are associated with altered relapse risk in multiple sclerosis: Results from a prospective cohort study; Journal of Neurology, Neurosurgery and Psychiatry
Stressful life events and the risk of initial central nervous system demyelination; Multiple Sclerosis Journal
Sun exposure across the life course significantly modulates early multiple sclerosis clinical course; Frontiers in Neurology
Sun exposure and vitamin D are independent risk factors for CNS demyelination; Neurology
Sun exposure over a lifetime in Australian adults from latitudinally diverse regions; Photochemistry and Photobiology
Sunshine and multiple sclerosis; Journal of Neurology, Neurosurgery and Psychiatry
Synergetic and antagonistic effects of combined calcitriol and interferon-β treatment on cytokine production by stimulated PBMCs; Journal of Neuroimmunology
Systematic Review of Cognitive Function in Euthymic Bipolar Disorder and Pre-Surgical Temporal Lobe Epilepsy; Frontiers in Psychiatry
The association between vitamin D and multiple sclerosis risk: 1,25(OH)2D3 induces super-enhancers bound by VDR; Frontiers in Immunology
The co-occurrence of multiple sclerosis and type 1 diabetes: Shared aetiologic features and clinical implication for MS aetiology; Journal of the Neurological Sciences
The cost of multiple sclerosis in Australia ; Journal of Clinical Neuroscience
The current status of the ketogenic diet in psychiatry; Frontiers in Psychiatry
The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells; Human Molecular Genetics
The economic impact of multiple sclerosis in Australia in 2010; Multiple Sclerosis
The effect of disease modifying therapies on disability progression in multiple sclerosis: A systematic overview of meta-analyses; Frontiers in Neurology
The effect of radiation therapy on the cognitive performance of high grade glioma patients; Australian Association of Neurologists 1997 Annual Scientific Meeting, 29 April-2 May 1997
The effect of season on cytokine expression in multiple sclerosis and healthy subjects; Journal of Neuroimmunology
The epidemiology of multiple sclerosis in the Isle of Man: 2006-2011; Acta Neurologica Scandinavica
The genetics of multiple sclerosis
The HLA-DR2 genotype does not affect MS severity, cognition or brain atrophy; 25th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis
The impact of multiple sclerosis severity on health state utility values: Evidence from Australia; Multiple Sclerosis Journal
The incidence of antibodies to Campylobacter species in healthy blood donors, patients with previous Campylobacter infections and patients with neurological disease; Medical Research Week
The major cause of multiple sclerosis is environmental: genetics has a minor role - Yes
The MS risk allele of CD40 is associated with reduced cell-membrane bound expression in antigen presenting cells: implications for gene function; PLoS One
The multiple sclerosis risk allele within the AHI1 gene is associated with relapses in children and adults; Multiple Sclerosis and Related Disorders
The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis ; Human Molecular Genetics
The natural history of asymptomatic meningiomas; Australian Association of Neurologists with the Association of British Neurologists, 29 April-2 May 1997
The natural history of asymptomatic meningiomas in Olmsted County, Minnesota; Neurology
The physical anthropometry, lifestyle habits and blood pressure of people presenting with a first clinical demyelinating event compared to controls: the Ausimmune study; Multiple Sclerosis Journal
The potential role of epigenetic modifications in the heritability of multiple sclerosis; Multiple Sclerosis Journal
The prevalence and demographic distribution of treated epilepsy: a community-based study in Tasmania, Australia; Acta Neurologica Scandinavica
The prevalence of potentialy neuropathic strains of Campylobacter within Tasmania using the Cholera toxin binding assay and pulse-field gel electrophoresis; Medical Research Week
The role of epidemiology in MS research: Past successes, current challenges and future potential; Multiple Sclerosis Journal
The role of latitude, ultraviolet radiation exposure and vitamin D in childhood asthma and hayfever: an Australian multicenter study ; Pediatric Allergy and Immunology
The role of vitamin D in multiple sclerosis: biology & biochemistry, epidemiology and potential roles in treatment; Medicinal Chemistry
The Scandinavian paradox revisited: Editorial comment on Berg-Hansen et al. 'High prevalence and no latitude gradient of multiple sclerosis in Norway'; Multiple Sclerosis Journal
The sensitivity and specificity of anti-GM1 antibody testing ; Neurology
The Tasmanian Epilepsy Register - A Community-Based Cohort: Background and methodology for patient recruitment from the Australian national prescription database; Neuroepidemiology
The Treatment of Multifocal Motor Neuropathy with Conduction Block (MMN-CB); Neurological Therapeutics: Principles and Practice
The Varied Mechanisms of Vitamin D in the Onset and Clinical Course of MS: Potential Roles in Modulating Other Etiological Pathways
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies; Journal of Clinical Neuroscience
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy; Journal of Clinical Neuroscience
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations; Journal of Clinical Neuroscience
Time to onset of secondary progression as an outcome in MS trials: a new paradigm?; Journal of Neurology, Neurosurgery and Psychiatry
Treatment of Multiple Sclerosis - Relationship between Vitamin D and Interferon β-1b; European Neurological Review
Trends in the epidemiology of multiple sclerosis in Greater Hobart, Tasmania: 1951 to 2009; Journal of Neurology, Neurosurgery and Psychiatry
Use of low-dose mitozantrone to treat aggressive multiple sclerosis: a single-centre open-label study using patient self-assessment and clinical measures of multiple sclerosis status; Internal Medicine Journal
Using normal variation in neuroanatomic traits to identify genes and pathways influencing disease: a joint linkage and association analysis of brain lesions; 8th GeneMappers Conference
Utility of serum Campylobacter specific antibodies in determining prior Campylobacter infection in neurological disease; Journal of Clinical Neuroscience
Validation of a clinical classification for subtypes of acute cerebral infarction; Journal of Neurology, Neurosurgery and Psychiatry
Validation of linear cerebral atrophy markers in multiple sclerosis; Journal of Clinical Neuroscience
Variability in vitamin D assays impairs clinical assessment of vitamin D status; Internal Medicine Journal
Variants of ST8SIA1 Are Associated with Risk of Developing Multiple Sclerosis; PLoS One
Variation within MBP gene predicts disease course in multiple sclerosis; Brain and Behavior
Vascular comorbidities in the onset and progression of multiple sclerosis; Journal of The Neurological Sciences
Vitamin D and multiple sclerosis; Journal of Clinical Neuroscience
Vitamin D for the treatment of multiple sclerosis: a meta-analysis; Journal of Neurology
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia; Journal of Neurology
Vitamin D status: Multifactorial contribution of environment, genes and other factors in healthy Australian adults across a latitude gradient; Journal of Steroid Biochemistry and Molecular Biology
Weekly cholecalciferol supplementation results in significant reductions in infection risk among the vitamin D deficient: results from the CIPRIS pilot RCT; BMC Nutrition
What is the actual prevalence of migraine?; Brain and Behavior
Who's missing out? Pharmionics and the immunomodulatory therapies for MS; 23rd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis

Research Projects

A double-blind randomised controlled trial to evaluate the efficacy of 20,000 IU/wk cholecalciferol in reducing respiratory tract infection in a cohort of healthy young adults; Royal Hobart Hospital Research Foundation (RHHRF)
A family-based approach to studying neurodegeneration in multiple sclerosis; University of Tasmania (UTAS)
Adopting a translational research paradigm to prevent or halt neurodegeneration in MS; Multiple Sclerosis Research Australia (MSRA)
Biomarkers to prevent disability in multiple sclerosis; National Health & Medical Research Council (NHMRC)
Case-control study in Primary Progressive MS: Are the risk factors the same as for people with RRMS onset and can we identify new ones?; Multiple Sclerosis Research Australia (MSRA)
Clinical safety assessment of rTMS application for the treatment of MS; Royal Hobart Hospital Research Foundation (RHHRF)
DEVA MS: DEvelopment and VAlidation of a cost effectiveness simulation model for Multiple Sclerosis and implications for health policy; Multiple Sclerosis Research Australia (MSRA)
Development of a therapeutic agent for a chemotherapy-induced neuropathy; Royal Hobart Hospital Research Foundation (RHHRF)
Do metallothioneins promote and direct regenerative growth of epidermal nerve fibres in diabetic peripheral neuropathy?; Brain Foundation (BrainF)
Does treating multiple sclerosis alter long-term disease outcomes? a natural history study; Multiple Sclerosis Research Australia (MSRA)
Effect of EBV and HHV-6 latent infection or reactivation on MS activity: a prospective clinical cohort study; National Health & Medical Research Council (NHMRC)
Environmental and genetic factors that influence the onset and progression of multiple sclerosis; Royal Hobart Hospital Research Foundation (RHHRF)
Examining the role of blood lipids and apolipoproteins on the progression of MS in a prospective clinical cohort; Royal Hobart Hospital Research Foundation (RHHRF)
Examining the role of lipids in the progression of MS in a prospective cohort study; Multiple Sclerosis Research Australia (MSRA)
Functional consequences of Multiple Sclerosis-associated genetic changes in Vitamin D metabolism genes in T cells and the pathogenesis of autoimmunity; Multiple Sclerosis Research Australia (MSRA)
Generating and characterizing a reliable rodent model type 2 diabetes; University of Tasmania (UTAS)
Identification of a Gene that Increases Risk of MS Via a Pathway Involving UV Exposure; National Health & Medical Research Council (NHMRC)
Identification of Genes that Influence MS Progression by Pathways that Involve UV Exposure: a Prospective Cohort Study; Ian Potter Foundation (IPF)
Identifying epigenetic factors involved in MS onset : utilising population-based studies with genetic and environmental measures; National Multiple Sclerosis Society (NMSS)
Identifying novel genetic loci associated with an increased relapse rate and disability progression in multiple sclerosis; Royal Hobart Hospital Research Foundation (RHHRF)
Identifying pathological pathways and putative therapeutics for the treatment of nervous system pathology in people with Multiple Sclerosis; Royal Hobart Hospital Research Foundation (RHHRF)
Identifying rare genetic variants conferring susceptibility to multiple sclerosis; National Health & Medical Research Council (NHMRC)
Imaging Genetics of Progression in Multiple Sclerosis; National Institutes of Health (NIH)
Investigating glutamate transporters in the brain?; University of Tasmania (UTAS)
Investigating the anti-inflammatory effect of a non-anticoagulant molecule of heparin following experimental traumatic brain injury; Royal Hobart Hospital Research Foundation (RHHRF)
Menzies Research Institute Senior Fellowship Support - Bruce Taylor; MS Society of Tasmania (MSTas)
Prognostic factors following a first episode of central nervous system demyelination suggestive of multiple sclerosis; National Health & Medical Research Council (NHMRC)
Promoting regrowth of nerve fibres into the epidermis during diabetic neuropathy by LRP agonists; National Health & Medical Research Council (NHMRC)
Select Foundation Fellowship - Prof Bruce Taylor; The Select Foundation (SelF)
The Australian Multi-Centre Study of Environment and Immune Function; National Multiple Sclerosis Society (NMSS)
The Cholecalciferol Intervention to Prevent Respiratory Infections Study (CIPRIS); The Select Foundation (SelF)
The effect of vitamin D and Interferon-beta on the immune response; Royal Hobart Hospital Research Foundation (RHHRF)
The modulation of multiple sclerosis (MS) relapse risk by genetic variations in the LRP2 gene; Royal Hobart Hospital Research Foundation (RHHRF)
The relationship between Immunoglobulin E (IgE), disease severity and the immune response in multiple sclerosis; Royal Hobart Hospital Research Foundation (RHHRF)
The role of environmental and genetic factors in progression of multiple sclerosis; National Health & Medical Research Council (NHMRC)
The Role of Personal UVR Exposure on the Clinical Course of MS: A Prospective Cohort Study; Trish Multiple Sclerosis Research Foundation (TMSRF)
The Role of Personal UVR Exposure on the Clinical Course of MS: a Prospective Cohort Study.; National Health & Medical Research Council (NHMRC)
The Tasmanian Epilepsy Register Health Study; Royal Hobart Hospital Research Foundation (RHHRF)
Validating novel serum markers of neurodegeneration in Multiple Sclerosis patients; National Health & Medical Research Council (NHMRC)
What predicts the progressive phase of multiple sclerosis?; National Health & Medical Research Council (NHMRC)
Australian MS Longitudinal study
Creating an MS Portal to achieve better outcomes for people with MS
Economic Impact of MS - 2007 cost of illness data AMSLS - PPMS sub-analysis
Economic Impact of MS in Australia Report (2018)
inforMS - a new patient-driven health care model for MS
inforMS- a new patient-driven health care model for MS
Multiple Sclerosis (MS) WorkSmart program: A novel online program to assist people living with MS in the workforce
Understanding MS MOOC (Massive Open Online Course)
VISIONARY-MS A Phase 2, Randomized, Double-Blind, Parallel Group, Placebo Controlled Study for the Treatment of Visual Pathway Deficits In Chronic Optic Neuropathy to Assess the Efficacy, Safety, Tol
A National MS Prevalence Study
Assessment of the cross reactivity between anti campylobacter antibodies and anti ganglioside antibodies in human neuropathic disorders.
Campylobacter project
Campylobacteriosis in Tasmania
Can infection with campylobacter species cause asymptomatic GBS
Correlation of disability, fatigue and depression measures in multiple sclerosis with magnetic resonance imaging measures of lesion load, atrophy and diffusion within normal-appearing white matter
New Start Research Fellowship
The role of pro and anti inflammatory cytokines in the progression of multiple sclerosis and the occurrence of relapses of multiple sclerosis and the relationships of cytokine profiles in MS patients to environmental UV exposure and vitamin D metabol
The seasonal variation in newly diagnosed MS patients cytokine profiles a case control study

Research Candidate Supervision

Comparing Bipolar Disorder and Epilepsy- Neuropsychological Profiles
Determinations of MS progression
Dissecting the Genetics Architecture of Multiple Sclerosis
Genetics of Complex Diseases
Identifying Genetic Variants and Environmental Factors Influencing MS Pathological Processes
Longitudinal Study of Multiple Sclerosis in Southern Tasmania- Description of Cohort and Impact of Demographic, Disease, Individual and Lifestyle Factors on Clinical Multiple Sclerosis Disability and Progression
LRP Receptors in a Novel Mechanism of Axon Pathfinding and Peripheral Nerve Regeneration
On the Geoepidemiology of Multiple Sclerosis and Environmental and Infectious Determinants of its Clinical Course
The Influence of HLA_DRA15 on Multiple Sclerosis
The Role of Epstein-Bar Virus and Human Herpes Virus 6 on the Progression of Multiple Sclerosis
The Role of Stress in Multiple Sclerosis Onset and Progression